Lot

NOR-202608-174

Purity

98.24%

As supplied

Form: Lyophilised powder
Storage: −20 °C, desiccated
Stability: 24 months
CAS: 863288-34-0
Formula: C165H269N47O46
Molecular weight: 3647.15 g/mol
Solubility: Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL

CJC-1295 DAC

GHRH(1-29) analogue with drug affinity complex

Northmark Research Compare brands

£49

Vial massCJC1295DAC-2-NOR

126 vials in stock · dispatched within 24 h

A tetrasubstituted GHRH(1-29) analogue bearing a maleimidoproprionic acid linker for covalent serum albumin conjugation. The DAC modification is the object of substantial pharmacokinetic literature.

Albumin-binding kineticsHalf-life modelling

Supplied for laboratory research use only. Not for human or veterinary use, consumption, or clinical application.

Analysis

Certificate of analysis

RP-HPLC chromatogramJanoshik Analytical

Retention time (min)λ 214 nm

Purity98.24%

Specification ≥ 98.0%

Lot: NOR-202608-174
Released: 2026-08-24
Mass expected: 3647.15 Da
Mass found: 3647.11 Da
Water (KF): 2.22%
Endotoxin: 0.083 EU/mg
Appearance: White lyophilisate

Signed COA · CJC-1295 DAC NOR-202608-174PDF ↓

Primary structure

30 residues

Hover a residue for detail

Formula: C165H269N47O46
Molecular weight: 3647.15 g/mol

Interactive

Reconstitution

Vial mass

Bacteriostatic watermL

Target quantity per drawmcg

Syringe

Draw to: 25.0 units
Volume: 0.250 mL
Concentration: 1.00 mg/mL
Draws per vial: 8

Arithmetic for CJC-1295 DAC at the values you entered. Not a protocol and not a dose recommendation. Research use only.

Handling

On arrival: Transfer to −20 °C within two hours. Vials ship on phase-change packs rated for 72 hours.
Reconstitution: Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
After reconstitution: 2–8 °C, use within 28 days. Aliquot to avoid freeze-thaw cycling.
Shelf life: 24 months lyophilised, desiccated and protected from light.